Name

Tamibarotene

Description

Tamibarotene is a novel synthetic retinoid for acute promyelocytic leukaemia (APL). Tamibarotene is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States.

Brands

Company not known

Amnoid

Company not known

Tamibaro